BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.040
-0.270 (-8.16%)
At close: Oct 30, 2026, 4:00 PM EST
3.100
+0.060 (1.97%)
Pre-market: Nov 2, 2026, 7:00 AM EST
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$2,181,516
Market Cap
26.81M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| NextCure | 40 |
| ABVC BioPharma | 19 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
BCTX News
- 5 days ago - BriaCell Therapeutics Annual report: Q4 2026 - Filings
- 5 days ago - BriaCell Therapeutics Report: Q4 2026 - Filings
- 5 days ago - BriaCell Therapeutics MD&A: Q4 2026 - Filings
- 10 days ago - BriaCell presents clinical biomarker findings from MBC patients at ESMO - TheFly
- 10 days ago - BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer - GlobeNewsWire
- 27 days ago - BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting - GlobeNewsWire
- 7 weeks ago - BriaCell announces DSMB recommendation to continue Bria-ABC study - TheFly
- 7 weeks ago - Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study - GlobeNewsWire